338 related articles for article (PubMed ID: 8083999)
1. trans activation by the full-length E2 proteins of human papillomavirus type 16 and bovine papillomavirus type 1 in vitro and in vivo: cooperation with activation domains of cellular transcription factors.
Ushikai M; Lace MJ; Yamakawa Y; Kono M; Anson J; Ishiji T; Parkkinen S; Wicker N; Valentine ME; Davidson I
J Virol; 1994 Oct; 68(10):6655-66. PubMed ID: 8083999
[TBL] [Abstract][Full Text] [Related]
2. Bovine papillomavirus type 1 E2 transcriptional regulators directly bind two cellular transcription factors, TFIID and TFIIB.
Rank NM; Lambert PF
J Virol; 1995 Oct; 69(10):6323-34. PubMed ID: 7666533
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional activity among high and low risk human papillomavirus E2 proteins correlates with E2 DNA binding.
Hou SY; Wu SY; Chiang CM
J Biol Chem; 2002 Nov; 277(47):45619-29. PubMed ID: 12239214
[TBL] [Abstract][Full Text] [Related]
4. DNA structure and flexibility in the sequence-specific binding of papillomavirus E2 proteins.
Hines CS; Meghoo C; Shetty S; Biburger M; Brenowitz M; Hegde RS
J Mol Biol; 1998 Mar; 276(4):809-18. PubMed ID: 9500925
[TBL] [Abstract][Full Text] [Related]
5. The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID.
Tan SH; Leong LE; Walker PA; Bernard HU
J Virol; 1994 Oct; 68(10):6411-20. PubMed ID: 8083979
[TBL] [Abstract][Full Text] [Related]
6. Suppression of cellular proliferation by the papillomavirus E2 protein.
Dowhanick JJ; McBride AA; Howley PM
J Virol; 1995 Dec; 69(12):7791-9. PubMed ID: 7494290
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the human papillomavirus E2 protein: evidence of trans-activation and trans-repression in cervical keratinocytes.
Bouvard V; Storey A; Pim D; Banks L
EMBO J; 1994 Nov; 13(22):5451-9. PubMed ID: 7957111
[TBL] [Abstract][Full Text] [Related]
8. Sequence-specific and general transcriptional activation by the bovine papillomavirus-1 E2 trans-activator require an N-terminal amphipathic helix-containing E2 domain.
Haugen TH; Turek LP; Mercurio FM; Cripe TP; Olson BJ; Anderson RD; Seidl D; Karin M; Schiller J
EMBO J; 1988 Dec; 7(13):4245-53. PubMed ID: 2854060
[TBL] [Abstract][Full Text] [Related]
9. Repression of bovine papillomavirus type 1 transcription by the E1 replication protein.
Sandler AB; Vande Pol SB; Spalholz BA
J Virol; 1993 Sep; 67(9):5079-87. PubMed ID: 8394436
[TBL] [Abstract][Full Text] [Related]
10. Control of human papillomavirus type 11 origin of replication by the E2 family of transcription regulatory proteins.
Chiang CM; Dong G; Broker TR; Chow LT
J Virol; 1992 Sep; 66(9):5224-31. PubMed ID: 1323690
[TBL] [Abstract][Full Text] [Related]
11. Competitive binding of viral E2 protein and mammalian core-binding factor to transcriptional control sequences of human papillomavirus type 8 and bovine papillomavirus type 1.
Schmidt HM; Steger G; Pfister H
J Virol; 1997 Oct; 71(10):8029-34. PubMed ID: 9311900
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional enhancer factor (TEF)-1 and its cell-specific co-activator activate human papillomavirus-16 E6 and E7 oncogene transcription in keratinocytes and cervical carcinoma cells.
Ishiji T; Lace MJ; Parkkinen S; Anderson RD; Haugen TH; Cripe TP; Xiao JH; Davidson I; Chambon P; Turek LP
EMBO J; 1992 Jun; 11(6):2271-81. PubMed ID: 1318197
[TBL] [Abstract][Full Text] [Related]
13. Conserved interaction of the papillomavirus E2 transcriptional activator proteins with human and yeast TFIIB proteins.
Benson JD; Lawande R; Howley PM
J Virol; 1997 Oct; 71(10):8041-7. PubMed ID: 9311902
[TBL] [Abstract][Full Text] [Related]
14. Enhanced transcriptional activation by E2 proteins from the oncogenic human papillomaviruses.
Kovelman R; Bilter GK; Glezer E; Tsou AY; Barbosa MS
J Virol; 1996 Nov; 70(11):7549-60. PubMed ID: 8892874
[TBL] [Abstract][Full Text] [Related]
15. An enhanced epithelial response of a papillomavirus promoter to transcriptional activators.
Vance KW; Campo MS; Morgan IM
J Biol Chem; 1999 Sep; 274(39):27839-44. PubMed ID: 10488130
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements.
Dong G; Broker TR; Chow LT
J Virol; 1994 Feb; 68(2):1115-27. PubMed ID: 8289341
[TBL] [Abstract][Full Text] [Related]
17. Specific in vitro interaction between papillomavirus E2 proteins and TBP-associated factors.
Carrillo E; Garrido E; Gariglio P
Intervirology; 2004; 47(6):342-9. PubMed ID: 15564746
[TBL] [Abstract][Full Text] [Related]
18. Transactivation-competent bovine papillomavirus E2 protein is specifically required for efficient repression of human papillomavirus oncogene expression and for acute growth inhibition of cervical carcinoma cell lines.
Goodwin EC; Naeger LK; Breiding DE; Androphy EJ; DiMaio D
J Virol; 1998 May; 72(5):3925-34. PubMed ID: 9557678
[TBL] [Abstract][Full Text] [Related]
19. Bovine papilloma virus (BPV)-encoded E2 protein enhances binding of E1 protein to the BPV replication origin.
Seo YS; Müller F; Lusky M; Gibbs E; Kim HY; Phillips B; Hurwitz J
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2865-9. PubMed ID: 8385347
[TBL] [Abstract][Full Text] [Related]
20. Regulation of human papillomavirus type 11 enhancer and E6 promoter by activating and repressing proteins from the E2 open reading frame: functional and biochemical studies.
Chin MT; Hirochika R; Hirochika H; Broker TR; Chow LT
J Virol; 1988 Aug; 62(8):2994-3002. PubMed ID: 2839716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
